Supernus Pharmaceuticals, Inc.
News
Bank of New York Mellon Corp Has $11.38 Million Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Ticker Report Bank of New York Mellon Corp increased its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 0.6% during the second quarter, according to its most recent 13F filing...\n more…
nVerses Capital LLC Makes New Investment in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Ticker Report nVerses Capital LLC bought a new position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities...\n more…
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Allspring Global Investments Holdings LLC
Ticker Report Allspring Global Investments Holdings LLC reduced its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 5.3% during the 2nd quarter, according to the company in its most...\n more…
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Position Lessened by Peregrine Capital Management LLC
Zolmax Peregrine Capital Management LLC lowered its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 0.3% during the second quarter, according to its most recent Form 13F filing...\n more…
Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
Globe Newswire ROCKVILLE, Md., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of...\n more…
Nisa Investment Advisors LLC Sells 388 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Zolmax Nisa Investment Advisors LLC lessened its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 19.0% in the 2nd quarter, according to its most recent Form 13F filing with the...\n more…